Toggle menu

ENCEPH UK

Start date:
March 2015
End date:
December 2015 (Close to recruitment)
Co-ordinated by:
Brain Infections UK, University of Liverpool
Main trial site:
http://www.encephuk.org/studies

To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.

 

Aim

To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.

Trial Design

A Prospective multi-centre cohort observational study.

Eligibility criteria (summary of )

Patients who present to the Emergency Department or Acute Medical Unit with suspected encephalitis

Chief Investigator

Professor Tom Solomon

Local PI

Dr Matt Reed

Research Team

EMERGE Research team in collaboration with the Acute Medical Unit (AMU), Critical Care and the Virology team at the RIE

Further information

For more information please refer to main trial website  

Local PI

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Polly Black

Senior Research Nurse

Julia Grahamslaw

Lead Research Nurse

More EMERGE Trials

Prospective multicentre observational study conducted over one calendar month in 2019, with the aim of describing the epidemiology of non-trauma related headache in adults presenting to emergency departments including investigations, treatments and outcome.

This will include adult patients presenting to the ED with non-trauma-related headache as their primary complaint.

Read more

HEAD Study

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Read more

SALI Study

SALI study - Significant Ankle Ligament Injury

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)